198
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Construction and Validation of TACE Therapeutic Efficacy by ALR Score and Nomogram: A Large, Multicenter Study

, , , , , ORCID Icon, , , , , , , ORCID Icon, , & ORCID Icon show all
Pages 1009-1017 | Received 29 Mar 2023, Accepted 02 Jun 2023, Published online: 29 Jun 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Yuan Wu, Xiaoli Liu, Xinhui Wang, Lihua Yu, Huiwen Yan, Yuqing Xie, Qing Pu, Xue Cai, Yaxian Kong & Zhiyun Yang. (2023) A Nomogram Prognostic Model for Advanced Hepatocellular Carcinoma Based on the Interaction Between CD8+T Cell Counts and Age. OncoTargets and Therapy 16, pages 753-766.
Read now
Zhikai Zheng, Jiongliang Wang, Tianqing Wu, Minrui He, Juncheng Wang, Yangxun Pan, Jinbin Chen, Dandan Hu, Li Xu, Yaojun Zhang, Minshan Chen & Zhongguo Zhou. (2023) Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy. Journal of Hepatocellular Carcinoma 10, pages 2117-2132.
Read now
Hai-Feng Liu, Yang Lu, Qing Wang, Yu-Jie Lu & Wei Xing. (2023) Machine Learning-Based CEMRI Radiomics Integrating LI-RADS Features Achieves Optimal Evaluation of Hepatocellular Carcinoma Differentiation. Journal of Hepatocellular Carcinoma 10, pages 2103-2115.
Read now
Jiaojiao Gong, Renjie Yu, Xiaoxia Hu, Huating Luo, Qingzhu Gao, Yadi Li, Guili Tan, Haiying Luo & Bo Qin. (2023) Development and Validation of a Novel Prognosis Model Based on a Panel of Three Immunogenic Cell Death-Related Genes for Non-Cirrhotic Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 10, pages 1609-1628.
Read now

Articles from other publishers (6)

Huanzhuo Mai, Xing Yang, Yulan Xie, Jie Zhou, Qing Wang, Yiru Wei, Yuecong Yang, Dongjia Lu, Li Ye, Ping Cui, Hao Liang & Jiegang Huang. (2024) The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease. Frontiers in Microbiology 14.
Crossref
Wei-Qiao Zhang, Qiao Zhang, Li Tan, Zhi-Feng Guan, Feng Tian, Hong-Tao Tang, Kun He & Wei-Qiang Chen. (2023) Postoperative adjuvant immunotherapy for high-risk hepatocellular carcinoma patients. Frontiers in Oncology 13.
Crossref
Shengke Zhang, Chenglu Jiang, Lai Jiang, Haiqing Chen, Jinbang Huang, Xinrui Gao, Zhijia Xia, Lisa Jia Tran, Jing Zhang, Hao Chi, Guanhu Yang & Gang Tian. (2023) Construction of a diagnostic model for hepatitis B-related hepatocellular carcinoma using machine learning and artificial neural networks and revealing the correlation by immunoassay. Tumour Virus Research 16, pages 200271.
Crossref
Zhenyong Xiao, Jinwei Li, Cong Liang, Yamei Liu, Yuxiu Zhang, Yuxia Zhang, Quan Liu & Xianlei Yan. (2023) Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma. Aging 15:21, pages 12275-12295.
Crossref
Shengke Zhang, Chenglu Jiang, Lai Jiang, Haiqing Chen, Jinbang Huang, Jieying Zhang, Rui Wang, Hao Chi, Guanhu Yang & Gang Tian. (2023) Uncovering the immune microenvironment and molecular subtypes of hepatitis B-related liver cirrhosis and developing stable a diagnostic differential model by machine learning and artificial neural networks. Frontiers in Molecular Biosciences 10.
Crossref
Dandan Wang, Jinfeng Zhang & Huijie Jiang. (2023) Development of predictive biomarkers for transarterial chemoembolization efficacy in hepatocellular carcinoma. Radiology of Infectious Diseases 10:3, pages 93-103.
Crossref